NCT02160249

Brief Summary

The purpose of this study is to determine whether community-based rehabilitation plus facility-based care is superior to facility-based care alone in reducing disability related to schizophrenia in rural Ethiopia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 10, 2014

Completed
1.2 years until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 26, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2017

Completed
Last Updated

May 10, 2017

Status Verified

May 1, 2017

Enrollment Period

1.6 years

First QC Date

June 3, 2014

Last Update Submit

May 9, 2017

Conditions

Keywords

SchizophreniaPsychotic disordersSchizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using DSM-IV criteria

Outcome Measures

Primary Outcomes (1)

  • Disability (36-item WHODAS (World Health Organisation Disability Assessment Schedule) 2.0)

    12 months

Secondary Outcomes (16)

  • Symptom severity (Brief Psychiatric Rating Scale- Expanded version (BPRS-E))

    6 and 12 months

  • Clinical Global Impression (CGI)

    6 and 12 months

  • Relapse (Longitudinal Interval Follow up Evaluation: DSM-IV version (LIFE))

    6 and 12 months

  • Disability (36-item WHODAS 2.0)

    6 months

  • Functioning (indigenous functioning scale)

    6 and 12 months

  • +11 more secondary outcomes

Other Outcomes (6)

  • Discrimination (DISC-12)

    6 and 12 months

  • Health service use and costs

    6 and 12 months

  • Depression (PHQ-9+1)

    6 and 12 months

  • +3 more other outcomes

Study Arms (2)

Community-based rehabilitation and facility based care

EXPERIMENTAL

Community-based rehabilitation is delivered to participants and their caregivers at their home by a specialist CBR worker. It comprises psychoeducation, adherence support, rehabilitation (including self-care and social skills), family support groups and accessing existing community organisations. It also involves community awareness raising and education and mobilisation of community leaders. Facility based care (usual care) consists of anti-psychotic medication prescribed by a nurse or clinical officer in a health centre and basic psycho-education.

Behavioral: Community-based rehabilitationOther: Facility based care

Facility-based care

ACTIVE COMPARATOR

Facility based care (usual care) consists of anti-psychotic medication prescribed by a nurse or clinical officer in a health centre and basic psycho-education.

Other: Facility based care

Interventions

Community-based rehabilitation and facility based care
Community-based rehabilitation and facility based careFacility-based care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Diagnosis of schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using (DSM-IV) criteria
  • Evidence of severe, enduring or disabling illness
  • Resident in kebele for \>6 months and no immediate plans to leave the kebele
  • Has a primary caregiver who is willing to participate in the study

You may not qualify if:

  • No specific criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry, College of Health Sciences, Addis Ababa University

Addis Ababa, Ethiopia

Location

Related Publications (5)

  • Dijkstra LG, Weiss HA, Birhane R, Medhin G, de Silva M, Hanlon C, Fekadu A, Asher L. Effects of community-based rehabilitation on caregivers of people with schizophrenia in Ethiopia in the RISE trial. BMC Psychiatry. 2025 Mar 11;25(1):231. doi: 10.1186/s12888-025-06651-4.

  • Asher L, Birhane R, Weiss HA, Medhin G, Selamu M, Patel V, De Silva M, Hanlon C, Fekadu A. Community-based rehabilitation intervention for people with schizophrenia in Ethiopia (RISE): results of a 12-month cluster-randomised controlled trial. Lancet Glob Health. 2022 Apr;10(4):e530-e542. doi: 10.1016/S2214-109X(22)00027-4.

  • Asher L, Fekadu A, Teferra S, De Silva M, Pathare S, Hanlon C. "I cry every day and night, I have my son tied in chains": physical restraint of people with schizophrenia in community settings in Ethiopia. Global Health. 2017 Jul 11;13(1):47. doi: 10.1186/s12992-017-0273-1.

  • Asher L, De Silva M, Hanlon C, Weiss HA, Birhane R, Ejigu DA, Medhin G, Patel V, Fekadu A. Community-based Rehabilitation Intervention for people with Schizophrenia in Ethiopia (RISE): study protocol for a cluster randomised controlled trial. Trials. 2016 Jun 24;17(1):299. doi: 10.1186/s13063-016-1427-9.

  • De Silva MJ, Breuer E, Lee L, Asher L, Chowdhary N, Lund C, Patel V. Theory of Change: a theory-driven approach to enhance the Medical Research Council's framework for complex interventions. Trials. 2014 Jul 5;15:267. doi: 10.1186/1745-6215-15-267.

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Mary De Silva, PhD MSc

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR
  • Abebaw Fekadu

    Addis Ababa University Department of Psychiatry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2014

First Posted

June 10, 2014

Study Start

September 1, 2015

Primary Completion

March 26, 2017

Study Completion

May 8, 2017

Last Updated

May 10, 2017

Record last verified: 2017-05

Locations